Merck Annual Report 2009

€ million	Note	Dec. 31, 2009	Dec. 31, 2008
Current assets
Cash and cash equivalents	[15]	541.4	692.7
Marketable securities and financial assets	[16]	1,503.2	176.8
Trade accounts receivable	[17]	1,788.7	1,659.4
Inventories	[18]	1,367.9	1,407.4
Other current assets	[19]	275.6	283.3
Tax receivables	[20]	55.3	139.1
		5,532.1	4,358.7
Non-current assets
Intangible assets	[21]	7,598.4	8,203.4
Property, plant and equipment	[22]	2,607.6	2,440.1
Investments at equity	[23]	1.6	1.3
Non-current financial assets	[24]	118.4	97.4
Financial assets covering pensions	[24]	209.6	–
Other non-current financial assets	[19]	99.5	63.7
Deferred tax assets	[12]	545.4	480.1
		11,180.5	11,286.0

Total assets		16,712.6	15,644.7


Current liabilities
Current financial liabilities	[25]	705.2	266.2
Trade accounts payable	[26]	935.7	843.7
Other current liabilities	[27]	638.2	694.2
Tax liabilities	[28]	274.5	347.2
Current provisions	[29]	266.4	227.1
		2,820.0	2,378.4
Non-current liabilities
Non-current financial liabilities	[25]	1,602.1	1,080.1
Other non-current liabilities	[27]	16.9	19.6
Non-current provisions	[29]	685.0	563.4
Provisions for pensions and other post-employment benefits	[30]	1,311.5	1,144.0
Deferred tax liabilities	[12]	763.5	896.2
		4,379.0	3,703.3
Net equity	[31]
Equity capital		565.2	565.2
Reserves		8,894.9	8,940.2
Minority interest		53.5	57.6
		9,513.6	9,563.0

Total liabilities and stockholders’ equity		16,712.6	15,644.7

Balance Sheet Audited